Last update :
29/10/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Vasodilator   Nitroprusside sodium  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Nipride Canada, Netherlands
Nipruss Egypt, Germany
Nitropress Iran, New Zealand, United States of America
Nitroprussiate FID France
Stability in solutions   injection   Stability in solutions : Nitroprusside sodium     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0,05 & 0,1 mg/ml 25°C Protect from light
48 Hour
1037

Glass Ringer’s lactate solution 0,05 & 0,1 mg/ml 25°C Protect from light
48 Hour
1037

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 & 0,1 mg/ml 25°C Protect from light
48 Hour
1037

Polyvinyl chloride Ringer’s lactate solution 0,05 & 0,1 mg/ml 25°C Protect from light
48 Hour
1037

Polypropylen Syringe Glucose 5% 0,001 mg/ml 20°C Protect from light
264 Day
2028
Level of evidence B
Polypropylen Syringe Glucose 5% 0,001 mg/ml 4°C Protect from light
264 Day
2028
Level of evidence B
Polypropylen Syringe Glucose 5% 0,5 & 1,67 mg/ml 25°C Protect from light
12 Hour
633
Level of evidence A
Polypropylen Syringe Glucose 5% 1 mg/ml 25°C Protect from light
24 Hour
196
Level of evidence D
Polypropylen Syringe Glucose 5% 1 mg/ml 4°C Protect from light
9 Day
3903
Level of evidence A+
  Mentions Légales